Novo Nordisk A/S
XMUN:NOV
Novo Nordisk A/S
XMUN:NOV
Price:
32.155
EUR
2.45%
Market Closed
Market Cap:
€108.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
Novo Nordisk A/S
XMUN:NOV
|
DK |
|
Mencast Holdings Ltd
SGX:5NF
|
SG |
|
P
|
Prosper Construction Holdings Ltd
HKEX:6816
|
HK |
|
Sportradar Group AG
NASDAQ:SRAD
|
CH |
|
B
|
Boombit SA
WSE:BBT
|
PL |
|
B
|
Bever Holding NV
AEX:BEVER
|
NL |
|
J
|
Jubilee Gold Exploration Ltd
XTSX:JUB
|
CA |
Multiples-Based Value
The Multiples-Based Value of one
NOV
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 32.155 EUR,
Novo Nordisk A/S
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NOV Multiples-Based Value
LOCKED
Multiples Across Competitors
NOV Competitors Multiples
Novo Nordisk A/S Competitors
Novo Nordisk A/S Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DK |
|
Novo Nordisk A/S
XMUN:NOV
|
1T EUR | 3.4 | 10.3 | 7.6 | 8.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
869B USD | 13.9 | 43.9 | 29.6 | 31.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
588.6B USD | 6.3 | 22 | 15.3 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.4 | 11.5 | 13 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
233B GBP | 5.3 | 30.6 | 16.9 | 23.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
297.7B USD | 4.6 | 16.4 | 10.1 | 12.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
231.9B CHF | 5.4 | 21.7 | 13.4 | 17.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
159.7B USD | 2.6 | 20.9 | 8 | 10.6 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.1B USD | 2.6 | 17.7 | 7.4 | 9.1 | |
| FR |
|
Sanofi SA
PAR:SAN
|
100.1B EUR | 2.1 | 12.8 | 10.7 | 10.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
